CSMVX Mutual Fund

CSMVX Mutual Fund

NAV$46.90
See how much of CSMVX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$161M
Expense Ratio
1.26%
Dividend Yield (Current)
-
Holdings
45
Inception Date
Feb 24, 2000
Fund Family
Congress Asset Management Company
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+10.28%
1 Year+7.52%
3 Year+12.75%
5 Year+10.08%
10 Year+17.49%

Asset Allocation

Stocks: 99.33%
Cash: 0.67%
See how much of CSMVX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LGNDLigand Pharmaceuticals, Inc.3.74%
EATBrinker Intl Inc3.51%
MOG.AMoog Inccommon Stock3.44%
TGTXTg Therapeutics Inc Common Stock3.44%
RGENRepligen Corp3.40%
Top 10 Concentration: 33.53%Report Date: Aug 31, 2026
Download all 45 holdings for CSMVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$6.81
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

CSMVX Mutual Fund Overview

CSMVX Mutual Fund (Congress Small Cap Growth Fund Retail Class) is managed by Congress Asset Management Company with $161.2M in net assets. CSMVX expense ratio is 1.26%, holding 45 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2000-02-24.

CSMVX performance shows a YTD return of 10.28%. The 1-year return is 7.52% and the 5-year return is 10.08%.

CSMVX top holdings include Ligand Pharmaceuticals, Inc. (3.7%), Brinker Intl Inc (3.5%), Moog Inccommon Stock (3.4%), Tg Therapeutics Inc Common Stock (3.4%), Repligen Corp (3.4%). Go to all CSMVX holdings, CSMVX sectors, or CSMVX dividends.

CSMVX can be compared against other funds. Use CSMVX overlap to find shared positions, or CSMVX vs another fund for a side-by-side view. CSMVX alternatives are available via the screener, along with tax-loss harvesting opportunities.